Delving into the Latest Updates on EnliTISA (Shanghai) Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Mouth and Tooth Diseases

Digestive System Disorders

Cardiovascular Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	1
Immune System Diseases	1
Infectious Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	2

Top 5 Target	Count

CysLT(Cysteinyl leukotriene receptor)	1

[Translation] A randomized, multicenter, dose-escalation, treatment extension phase I/IIa clinical study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of TISA-818 oral rinse administered topically via the oral mucosa for the prevention and treatment of radiation oral mucositis in patients with head and neck cancer

主要目的是评估TISA-818含漱液在头颈部肿瘤患者中的安全性、有效性和耐受性；次要目的是考察TISA-818含漱液在头颈部肿瘤患者中的药代动力学（PK）特征。

[Translation]

The primary objective is to evaluate the safety, efficacy, and tolerability of TISA-818 oral rinse in patients with head and neck cancer; the secondary objective is to investigate the pharmacokinetic (PK) characteristics of TISA-818 oral rinse in patients with head and neck cancer.

Start Date05 Sep 2024

Sponsor / Collaborator

EnliTISA (Shanghai) Pharmaceutical Co., Ltd.

CTR20232329 / Active, not recruitingPhase 2

评价孟鲁司特钠凝胶在痔疮手术患者中的安全性和耐受性、药代动力学特征及有效性的多中心、随机、双盲、安慰剂对照IIa期临床研究

[Translation] A multicenter, randomized, double-blind, placebo-controlled phase IIa clinical study to evaluate the safety and tolerability, pharmacokinetic characteristics and efficacy of montelukast sodium gel in patients undergoing hemorrhoid surgery

主要目的：评价不同剂量孟鲁司特钠凝胶用于痔疮手术患者的安全性和耐受性。次要目的：评价不同剂量孟鲁司特钠凝胶改善痔疮手术患者症状的疗效；评价孟鲁司特钠凝胶在痔疮手术患者中的药代动力学（PK）特征；探索孟鲁司特钠凝胶在痔疮手术患者中的III期临床推荐剂量。

[Translation]

Primary objective: To evaluate the safety and tolerability of different doses of montelukast sodium gel in patients undergoing hemorrhoid surgery. Secondary objective: To evaluate the efficacy of different doses of montelukast sodium gel in improving symptoms in patients undergoing hemorrhoid surgery; to evaluate the pharmacokinetic (PK) characteristics of montelukast sodium gel in patients undergoing hemorrhoid surgery; to explore the recommended dose of montelukast sodium gel in Phase III clinical trials in patients undergoing hemorrhoid surgery.

Start Date13 Aug 2023

Sponsor / Collaborator

EnliTISA (Shanghai) Pharmaceutical Co., Ltd.

100 Clinical Results associated with EnliTISA (Shanghai) Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with EnliTISA (Shanghai) Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with EnliTISA (Shanghai) Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with EnliTISA (Shanghai) Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Phase 2

Login to view more data